PTC Therapeutics, Inc. (PTCT) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT
Company Participants
Ellen Cavaleri - Head of Investor Relations
Matthew Klein - CEO & Director
Eric Pauwels - Chief Business Officer
Pierre Gravier - Chief Financial Officer
Conference Call Participants
Kristen Kluska - Cantor Fitzgerald & Co., Research Division
Tazeen Ahmad - BofA Securities, Research Division
Benjamin Burnett - Wells Fargo Securities, LLC, Research Division
Eliana Merle - Barclays Bank PLC, Research Division
Lut Ming Cheng - JPMorgan Chase & Co, Research Division
Judah Frommer - Morgan Stanley, Research Division
Jarwei Fang - Citigroup Inc., Research Division
Kevin Meli - RBC Capital Markets, Research Division
Yifan Xu - Jefferies LLC, Research Division
Jacob Ormes
Luke Herrmann - Robert W. Baird & Co. Incorporated, Research Division
Jenny Leigh Gonzalez-Armenta - Leerink Partners LLC, Research Division
Kyuwon Choi - Goldman Sachs Group, Inc., Research Division
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics' First Quarter 2026 Earnings Conference Call. [Operator Instructions] Today's conference is being recorded.
I would now like to turn the call over to Ellen Cavaleri, Head of Investor Relations. Please go ahead.
Ellen Cavaleri
Head of Investor Relations
Good afternoon, and thank you for joining us to discuss PTC Therapeutics' First Quarter 2026 Corporate Update and Financial Results.
I'm joined today by our Chief Executive Officer, Dr. Matthew Klein; our Chief Business Officer, Eric Pauwels; and our Chief Financial Officer, Pierre Gravier.
Today's call will include forward-looking statements based on our current expectations. These statements are subject to certain risks and uncertainties, and actual results may differ materially. Please review the slide posted on our Investor Relations website in conjunction with the call, which contains information about our forward-looking statements and our most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K filed with the SEC, as well as our other SEC filings for
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。